POLYETHYLENE GLYCOL 3350

POLYETHYLENE GLYCOL 3350 was reported 96561 times

POLYETHYLENE GLYCOL 3350 is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INAPPROPRIATE PRESCRIBING 466 0.7565
1 ANTACID THERAPY 83 0.6385
2 SLEEP DISORDER THERAPY 123 0.6212
3 APPENDICOLITH 221 0.5711
4 ANALGESIC THERAPY 126 0.3925
5 DRUG THERAPY 118 0.3481
6 ANTICOAGULANT THERAPY 83 0.2923
7 CONGENITAL HIATUS HERNIA 61 0.2675
8 EXPOSURE TO UNSPECIFIED AGENT 47 0.2398
9 VAGINAL FLATULENCE 70 0.2310
10 MALIGNANT MELANOMA STAGE 0 48 0.2297
11 INTERCEPTED DRUG PRESCRIBING ERROR 96 0.1943
12 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1024 0.1428
13 INCORRECT PRODUCT ADMINISTRATION DURATION 2362 0.1089
14 CEREBRAL HYPOPERFUSION 50 0.1073
15 FAECAL VOLUME DECREASED 50 0.1042
16 INCORRECT DRUG ADMINISTRATION DURATION 2837 0.1008
17 PRODUCT PRESCRIBING ISSUE 2021 0.0927
18 HYPERPHOSPHATAEMIA 185 0.0860
19 FAECES HARD 307 0.0788
20 BLOOD PHOSPHORUS INCREASED 208 0.0761
21 ABNORMAL FAECES 587 0.0716
22 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 63 0.0680
23 DRUG EFFECT DELAYED 290 0.0639
24 PRODUCT CONTAMINATION PHYSICAL 150 0.0590
25 GASTROINTESTINAL MOTILITY DISORDER 307 0.0573
26 PRODUCT TASTE ABNORMAL 757 0.0559
27 PRODUCT SOLUBILITY ABNORMAL 281 0.0556
28 INFREQUENT BOWEL MOVEMENTS 138 0.0554
29 EXPIRED PRODUCT ADMINISTERED 1784 0.0536
30 PRODUCT USE ISSUE 10036 0.0533
31 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 290 0.0532
32 FAECES SOFT 362 0.0497
33 FEMALE GENITAL TRACT FISTULA 83 0.0486
34 INCORRECT DOSAGE ADMINISTERED 232 0.0474
35 BOWEL MOVEMENT IRREGULARITY 348 0.0454
36 POOR QUALITY DRUG ADMINISTERED 290 0.0448
37 PRODUCT ODOUR ABNORMAL 467 0.0445
38 DYSCHEZIA 133 0.0435
39 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1379 0.0408
40 FAECAL INCONTINENCE 187 0.0389
41 RADICULOPATHY 101 0.0383
42 CHRONIC SINUSITIS 140 0.0373
43 EXPIRED DRUG ADMINISTERED 184 0.0371
44 FREQUENT BOWEL MOVEMENTS 990 0.0366
45 THERAPEUTIC PRODUCT EFFECT DELAYED 167 0.0366
46 PRODUCT LABEL CONFUSION 212 0.0363
47 DRUG PRESCRIBING ERROR 696 0.0362
48 FLATULENCE 1998 0.0352
49 THERAPEUTIC PRODUCT EFFECT VARIABLE 134 0.0345
50 NEPHROGENIC ANAEMIA 159 0.0343
51 FAECALOMA 187 0.0341
52 ANAL INCONTINENCE 305 0.0339
53 IRON DEFICIENCY 152 0.0338
54 PROCTITIS 91 0.0325
55 TOTAL LUNG CAPACITY DECREASED 51 0.0319
56 HYPERPARATHYROIDISM SECONDARY 80 0.0319
57 ESSENTIAL HYPERTENSION 58 0.0317
58 AORTIC STENOSIS 110 0.0316
59 TIC 170 0.0311
60 BLOOD URIC ACID INCREASED 168 0.0291
61 NEUROGENIC BLADDER 59 0.0279
62 APPENDICITIS 260 0.0278
63 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 140 0.0276
64 HYPOPHOSPHATAEMIA 203 0.0274
65 GASTROINTESTINAL SOUNDS ABNORMAL 136 0.0274
66 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 166 0.0273
67 PRODUCT PACKAGE ASSOCIATED INJURY 60 0.0269
68 CHANGE OF BOWEL HABIT 55 0.0268
69 PLEURITIC PAIN 73 0.0264
70 FAILURE TO THRIVE 132 0.0254
71 RHINOVIRUS INFECTION 98 0.0252
72 CONSTIPATION 5484 0.0251
73 UNDERDOSE 1822 0.0249
74 CYSTIC FIBROSIS 137 0.0247
75 PRODUCT PACKAGING DIFFICULT TO OPEN 64 0.0245
76 FAECES DISCOLOURED 515 0.0237
77 HOSPICE CARE 232 0.0235
78 DRUG EFFECT INCREASED 74 0.0234
79 ABDOMINAL DISTENSION 2340 0.0224
80 MYASTHENIA GRAVIS 181 0.0224
81 POOR QUALITY PRODUCT ADMINISTERED 234 0.0222
82 VENTRICULAR FIBRILLATION 246 0.0221
83 PROCTALGIA 139 0.0216
84 CARBOHYDRATE ANTIGEN 125 INCREASED 73 0.0214
85 ATELECTASIS 206 0.0213
86 LUNG OPACITY 54 0.0205
87 TROPONIN INCREASED 154 0.0202
88 BREATH SOUNDS ABNORMAL 99 0.0201
89 DEFAECATION URGENCY 138 0.0197
90 HYPERLIPIDAEMIA 230 0.0192
91 RESPIRATORY SYMPTOM 54 0.0190
92 DECUBITUS ULCER 153 0.0188
93 CARDIOGENIC SHOCK 268 0.0187
94 EXTRA DOSE ADMINISTERED 752 0.0185
95 END STAGE RENAL DISEASE 336 0.0184
96 BENIGN PROSTATIC HYPERPLASIA 95 0.0184
97 SUSPECTED OFF LABEL USE 83 0.0184
98 ANORECTAL DISCOMFORT 95 0.0179
99 MACULAR DEGENERATION 213 0.0178
100 SMALL INTESTINAL OBSTRUCTION 218 0.0177
101 HAEMORRHAGIC ANAEMIA 77 0.0175
102 MICTURITION URGENCY 197 0.0172
103 HAEMORRHOIDAL HAEMORRHAGE 83 0.0170
104 BLOOD CALCIUM INCREASED 149 0.0170
105 LUNG CONSOLIDATION 47 0.0168
106 NON-CARDIAC CHEST PAIN 53 0.0167
107 PRODUCT PHYSICAL CONSISTENCY ISSUE 90 0.0162
108 ON AND OFF PHENOMENON 89 0.0160
109 GASTROINTESTINAL PAIN 176 0.0160
110 FREEZING PHENOMENON 59 0.0159
111 HYPOPNOEA 55 0.0158
112 ASPIRATION 173 0.0158
113 DIVERTICULUM INTESTINAL 68 0.0155
114 OBSESSIVE-COMPULSIVE DISORDER 124 0.0154
115 SCREAMING 98 0.0154
116 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1091 0.0153
117 FUNCTIONAL GASTROINTESTINAL DISORDER 53 0.0153
118 PRODUCT LABEL ISSUE 104 0.0153
119 HAEMORRHOIDS 299 0.0153
120 THERAPEUTIC PRODUCT INEFFECTIVE 59 0.0152
121 PRODUCT USE IN UNAPPROVED INDICATION 3776 0.0152
122 ACUTE RESPIRATORY FAILURE 290 0.0151
123 POSTURE ABNORMAL 49 0.0150
124 SPINAL OSTEOARTHRITIS 132 0.0150
125 MALNUTRITION 168 0.0150
126 NOCTURIA 182 0.0150
127 IMPAIRED GASTRIC EMPTYING 200 0.0147
128 BEHAVIOUR DISORDER 78 0.0144
129 COMPRESSION FRACTURE 77 0.0144
130 ASCITES 422 0.0143
131 SNORING 54 0.0143
132 NEURALGIA 347 0.0143
133 PULMONARY FUNCTION TEST DECREASED 62 0.0141
134 BONE LESION 51 0.0141
135 BRONCHIECTASIS 95 0.0141
136 DIVERTICULUM 100 0.0141
137 SLEEP TERROR 59 0.0140
138 BLOOD SODIUM DECREASED 264 0.0140
139 BACTERIAL INFECTION 261 0.0140
140 DYSPHEMIA 61 0.0139
141 SPINAL CORD COMPRESSION 54 0.0139
142 PROTEIN TOTAL DECREASED 52 0.0138
143 CEREBRAL ATROPHY 55 0.0138
144 RENAL FAILURE CHRONIC 106 0.0138
145 BLOOD ALBUMIN DECREASED 108 0.0136
146 LEFT VENTRICULAR HYPERTROPHY 58 0.0135
147 SKIN ABRASION 64 0.0135
148 SCOLIOSIS 83 0.0134
149 PRESCRIBED UNDERDOSE 267 0.0134
150 PRE-EXISTING CONDITION IMPROVED 82 0.0131
151 PRODUCT USE COMPLAINT 205 0.0130
152 INTERCEPTED MEDICATION ERROR 60 0.0129
153 RETCHING 276 0.0129
154 CARDIAC MURMUR 112 0.0129
155 RED CELL DISTRIBUTION WIDTH INCREASED 53 0.0127
156 INFUSION SITE SWELLING 80 0.0127
157 RALES 73 0.0126
158 EPIGASTRIC DISCOMFORT 49 0.0125
159 INTERVERTEBRAL DISC DEGENERATION 116 0.0125
160 MUSCLE SPASTICITY 154 0.0125
161 INCORRECT DOSE ADMINISTERED 2858 0.0125
162 DRUG EFFECT DECREASED 667 0.0124
163 MENTAL STATUS CHANGES 341 0.0123
164 ORAL CANDIDIASIS 161 0.0122
165 INCORRECT DRUG ADMINISTRATION RATE 52 0.0122
166 DRUG EFFECT LESS THAN EXPECTED 180 0.0121
167 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 208 0.0121
168 PRODUCT ADMINISTRATION INTERRUPTED 95 0.0121
169 ANGER 408 0.0121
170 IRON DEFICIENCY ANAEMIA 111 0.0120
171 DROOLING 83 0.0120
172 ESCHERICHIA URINARY TRACT INFECTION 51 0.0120
173 HYPONATRAEMIA 674 0.0120
174 ILEUS 148 0.0119
175 INFUSION SITE ERYTHEMA 99 0.0117
176 INTESTINAL OBSTRUCTION 442 0.0117
177 HAEMATOCRIT DECREASED 232 0.0117
178 RECTAL HAEMORRHAGE 502 0.0117
179 PRESCRIBED OVERDOSE 225 0.0116
180 MULTIPLE MYELOMA 54 0.0116
181 HYPOPHAGIA 295 0.0115
182 PARAESTHESIA ORAL 166 0.0115
183 ULCER 182 0.0114
184 GOUT 204 0.0114
185 HEPATIC LESION 49 0.0113
186 BLOOD CALCIUM DECREASED 127 0.0113
187 DIARRHOEA 7279 0.0113
188 HYDRONEPHROSIS 84 0.0112
189 DEHYDRATION 1488 0.0111
190 HYPOVOLAEMIA 65 0.0111
191 BLOOD POTASSIUM DECREASED 334 0.0111
192 LOWER GASTROINTESTINAL HAEMORRHAGE 82 0.0111
193 TRICUSPID VALVE INCOMPETENCE 88 0.0111
194 ABDOMINAL TENDERNESS 55 0.0111
195 ABDOMINAL PAIN UPPER 2278 0.0111
196 HIATUS HERNIA 143 0.0110
197 ABDOMINAL PAIN 2566 0.0110
198 VASCULAR DEVICE INFECTION 50 0.0110
199 SPINAL COLUMN STENOSIS 52 0.0110
200 PSEUDOMONAS INFECTION 93 0.0108
201 BLOOD POTASSIUM INCREASED 176 0.0108
202 BLOOD TEST ABNORMAL 152 0.0108
203 BLOOD MAGNESIUM DECREASED 93 0.0108
204 FLANK PAIN 101 0.0108
205 ABNORMAL BEHAVIOUR 426 0.0107
206 BACTERAEMIA 127 0.0107
207 PRODUCT PREPARATION ISSUE 70 0.0107
208 INCONTINENCE 112 0.0106
209 OFF LABEL USE 9245 0.0105
210 COLITIS ISCHAEMIC 71 0.0105
211 ABDOMINAL HERNIA 48 0.0105
212 HYPERVOLAEMIA 52 0.0105
213 PERIPHERAL VASCULAR DISORDER 54 0.0105
214 INFUSION SITE PAIN 135 0.0105
215 MITRAL VALVE INCOMPETENCE 118 0.0104
216 MULTIPLE ORGAN DYSFUNCTION SYNDROME 295 0.0104
217 SPINAL COMPRESSION FRACTURE 86 0.0104
218 FRUSTRATION TOLERANCE DECREASED 84 0.0104
219 URINE ODOUR ABNORMAL 61 0.0104
220 PRODUCT PRESCRIBING ERROR 246 0.0103
221 HYPOXIA 363 0.0103
222 RESPIRATORY SYNCYTIAL VIRUS INFECTION 89 0.0102
223 DRY MOUTH 823 0.0101
224 SPUTUM DISCOLOURED 96 0.0101
225 URINARY TRACT INFECTION 1720 0.0101
226 URINE OUTPUT DECREASED 88 0.0101
227 AGGRESSION 501 0.0100
228 PNEUMONIA ASPIRATION 250 0.0100
229 DIZZINESS POSTURAL 97 0.0100
230 ORAL DISCOMFORT 138 0.0099
231 ORAL PAIN 222 0.0099
232 RED BLOOD CELL COUNT DECREASED 281 0.0098
233 MUSCULOSKELETAL CHEST PAIN 152 0.0098
234 PULMONARY MASS 145 0.0097
235 URINARY RETENTION 324 0.0097
236 SLEEP APNOEA SYNDROME 185 0.0097
237 VAGINAL DISCHARGE 98 0.0097
238 GINGIVAL PAIN 77 0.0097
239 LEUKOCYTOSIS 175 0.0097
240 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 283 0.0097
241 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 501 0.0096
242 UROSEPSIS 88 0.0095
243 PERONEAL NERVE PALSY 54 0.0095
244 DECREASED INTEREST 56 0.0095
245 SEPSIS 1056 0.0095
246 POLLAKIURIA 393 0.0094
247 URINARY INCONTINENCE 279 0.0094
248 SEASONAL ALLERGY 133 0.0094
249 HALLUCINATION 708 0.0094
250 BLADDER DISORDER 93 0.0094
251 FULL BLOOD COUNT ABNORMAL 99 0.0094
252 ANAL FISSURE 50 0.0093
253 PLEURAL EFFUSION 567 0.0093
254 MULTIPLE ALLERGIES 73 0.0093
255 TENDERNESS 97 0.0093
256 RHINITIS 75 0.0093
257 ELECTROLYTE IMBALANCE 108 0.0093
258 HYPERCALCAEMIA 114 0.0092
259 FEBRILE NEUTROPENIA 610 0.0092
260 HALLUCINATION, VISUAL 194 0.0092
261 IRRITABLE BOWEL SYNDROME 197 0.0092
262 FULL BLOOD COUNT DECREASED 185 0.0092
263 WEIGHT FLUCTUATION 96 0.0092
264 DELUSION 142 0.0091
265 VITAMIN D DEFICIENCY 89 0.0091
266 PRODUCT PHYSICAL ISSUE 184 0.0091
267 LYMPHOEDEMA 63 0.0091
268 DYSURIA 335 0.0091
269 SWOLLEN TONGUE 283 0.0091
270 PROTHROMBIN TIME PROLONGED 54 0.0090
271 CARDIOMEGALY 111 0.0090
272 HYPERCHOLESTEROLAEMIA 86 0.0089
273 HYPOALBUMINAEMIA 69 0.0089
274 THERAPEUTIC RESPONSE UNEXPECTED 397 0.0088
275 DYSGEUSIA 655 0.0088
276 GASTRITIS 232 0.0088
277 GASTROENTERITIS VIRAL 159 0.0088
278 HAEMOPTYSIS 244 0.0087
279 ONYCHOCLASIS 60 0.0087
280 RENAL CYST 69 0.0087
281 ABDOMINAL DISCOMFORT 1457 0.0087
282 HAEMATOCHEZIA 479 0.0087
283 CLOSTRIDIUM DIFFICILE COLITIS 92 0.0087
284 TASTE DISORDER 176 0.0087
285 ECONOMIC PROBLEM 131 0.0086
286 BODY HEIGHT DECREASED 92 0.0086
287 DYSPHONIA 503 0.0086
288 UPPER GASTROINTESTINAL HAEMORRHAGE 143 0.0085
289 DENTAL CARIES 94 0.0085
290 UPPER-AIRWAY COUGH SYNDROME 70 0.0085
291 WALKING AID USER 56 0.0085
292 ERUCTATION 164 0.0085
293 RENAL TUBULAR NECROSIS 83 0.0085
294 GASTROOESOPHAGEAL REFLUX DISEASE 678 0.0084
295 EATING DISORDER 179 0.0084
296 TRANSFUSION 88 0.0084
297 PAROSMIA 63 0.0083
298 HIP FRACTURE 268 0.0083
299 OESOPHAGITIS 91 0.0083
300 ECCHYMOSIS 57 0.0083
301 DYSPEPSIA 812 0.0082
302 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 56 0.0082
303 HYPERTONIA 47 0.0082
304 UPPER RESPIRATORY TRACT INFECTION 379 0.0082
305 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 450 0.0082
306 INCREASED TENDENCY TO BRUISE 75 0.0081
307 ATRIAL FLUTTER 65 0.0081
308 SECRETION DISCHARGE 102 0.0081
309 NASAL DRYNESS 51 0.0081
310 SOCIAL AVOIDANT BEHAVIOUR 47 0.0081
311 UNRESPONSIVE TO STIMULI 209 0.0081
312 ABDOMINAL PAIN LOWER 204 0.0081
313 PRODUCTIVE COUGH 385 0.0081
314 RESPIRATORY DISTRESS 221 0.0080
315 NEUROPATHY PERIPHERAL 759 0.0080
316 CELLULITIS 402 0.0080
317 HYPOKALAEMIA 368 0.0080
318 DECREASED ACTIVITY 86 0.0080
319 ANAEMIA 1519 0.0080
320 PNEUMONIA BACTERIAL 73 0.0079
321 COLITIS 301 0.0079
322 MUSCLE SPASMS 1456 0.0079
323 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1605 0.0079
324 LYMPHOCYTE COUNT DECREASED 140 0.0079
325 OSTEOPENIA 120 0.0079
326 HYPERSOMNIA 226 0.0079
327 GASTRIC DISORDER 270 0.0079
328 PELVIC FRACTURE 61 0.0078
329 DECREASED APPETITE 1819 0.0078
330 WEIGHT DECREASED 2183 0.0078
331 DEEP VEIN THROMBOSIS 508 0.0078
332 THERAPEUTIC PRODUCT EFFECT DECREASED 350 0.0078
333 DIVERTICULITIS 216 0.0078
334 POLYP 51 0.0078
335 CHRONIC KIDNEY DISEASE 591 0.0078
336 LARGE INTESTINE PERFORATION 54 0.0078
337 BLOOD IRON DECREASED 92 0.0077
338 ARTERIOSCLEROSIS CORONARY ARTERY 51 0.0077
339 BALANCE DISORDER 665 0.0077
340 POOR QUALITY SLEEP 165 0.0077
341 STAPHYLOCOCCAL INFECTION 252 0.0076
342 DRUG INEFFECTIVE 10049 0.0076
343 CHOLECYSTITIS CHRONIC 51 0.0076
344 HAEMOGLOBIN ABNORMAL 49 0.0076
345 SINUS TACHYCARDIA 108 0.0076
346 PARANOIA 131 0.0076
347 DYSPHAGIA 721 0.0076
348 BLOOD UREA INCREASED 127 0.0076
349 ORTHOSTATIC HYPOTENSION 132 0.0076
350 HAEMOGLOBIN DECREASED 777 0.0076
351 PLATELET COUNT DECREASED 806 0.0076
352 INFUSION SITE EXTRAVASATION 47 0.0075
353 CYSTITIS 240 0.0075
354 JOINT INJURY 161 0.0075
355 CHOKING 147 0.0075
356 MUSCLE TIGHTNESS 122 0.0075
357 GROIN PAIN 66 0.0075
358 LARGE INTESTINE POLYP 52 0.0075
359 SEIZURE 867 0.0075
360 PNEUMOTHORAX 119 0.0075
361 RIB FRACTURE 154 0.0075
362 LETHARGY 430 0.0075
363 OEDEMA PERIPHERAL 911 0.0075
364 LUNG INFILTRATION 66 0.0075
365 PROCEDURAL PAIN 207 0.0075
366 SLEEP DISORDER 526 0.0074
367 PULMONARY EMBOLISM 708 0.0074
368 EYE MOVEMENT DISORDER 51 0.0074
369 ARTERIOSCLEROSIS 70 0.0074
370 ASTHENIA 2791 0.0074
371 VOMITING 3486 0.0074
372 BRAIN FOG 116 0.0074
373 APPETITE DISORDER 49 0.0074
374 CANDIDA INFECTION 124 0.0073
375 DYSKINESIA 298 0.0073
376 GASTROENTERITIS 107 0.0073
377 ENCEPHALOPATHY 180 0.0073
378 SINUS DISORDER 145 0.0073
379 HICCUPS 60 0.0073
380 CHROMATURIA 165 0.0073
381 NEPHROPATHY 68 0.0073
382 PRESYNCOPE 177 0.0073
383 FALL 2422 0.0073
384 CONFUSIONAL STATE 1162 0.0072
385 MIDDLE INSOMNIA 134 0.0072
386 NERVE COMPRESSION 66 0.0071
387 DYSPNOEA EXERTIONAL 269 0.0071
388 BLOOD ALKALINE PHOSPHATASE INCREASED 177 0.0071
389 DERMATITIS CONTACT 81 0.0071
390 NAUSEA 5621 0.0071
391 BLOOD CREATININE INCREASED 462 0.0071
392 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 503 0.0071
393 EAR INFECTION 188 0.0071
394 DEMENTIA 197 0.0070
395 INITIAL INSOMNIA 72 0.0070
396 STOMATITIS 425 0.0070
397 BLOOD URINE PRESENT 133 0.0070
398 BLOOD PRESSURE INCREASED 1071 0.0070
399 FEELING COLD 195 0.0070
400 AFFECTIVE DISORDER 55 0.0070
401 HEAD INJURY 221 0.0070
402 INTENTIONAL UNDERDOSE 51 0.0070
403 HERNIA 135 0.0070
404 PULMONARY CONGESTION 92 0.0070
405 BLOOD CHOLESTEROL INCREASED 325 0.0070
406 POSTOPERATIVE WOUND INFECTION 47 0.0070
407 SKIN INFECTION 78 0.0069
408 CYTOKINE RELEASE SYNDROME 139 0.0069
409 WHITE BLOOD CELL COUNT DECREASED 751 0.0069
410 FACIAL PARALYSIS 59 0.0069
411 HYPOTONIA 69 0.0069
412 CORONARY ARTERY DISEASE 209 0.0069
413 PLASMA CELL MYELOMA 269 0.0069
414 PNEUMONIA 2230 0.0069
415 DRY THROAT 70 0.0069
416 CHOLECYSTITIS 82 0.0069
417 VIRAL INFECTION 229 0.0069
418 DRUG ADMINISTRATION ERROR 211 0.0069
419 PULMONARY HYPERTENSION 143 0.0069
420 ATRIAL FIBRILLATION 668 0.0069
421 RESPIRATORY FAILURE 498 0.0068
422 DEVICE OCCLUSION 96 0.0068
423 ESCHERICHIA INFECTION 56 0.0068
424 FEEDING DISORDER 138 0.0068
425 MUSCULAR WEAKNESS 773 0.0068
426 OSTEOMYELITIS 123 0.0068
427 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1224 0.0068
428 GASTROINTESTINAL DISORDER 608 0.0068
429 TONGUE DISORDER 49 0.0068
430 POST PROCEDURAL INFECTION 55 0.0068
431 NECK PAIN 377 0.0067
432 ATAXIA 80 0.0067
433 PRODUCT PACKAGING ISSUE 64 0.0067
434 SPEECH DISORDER 352 0.0067
435 MAJOR DEPRESSION 49 0.0067
436 FIBROMYALGIA 163 0.0067
437 MUSCLE STRAIN 58 0.0067
438 BACK PAIN 1556 0.0067
439 PRODUCT DISTRIBUTION ISSUE 62 0.0067
440 FLUID OVERLOAD 97 0.0067
441 BLOOD PRESSURE ABNORMAL 132 0.0066
442 INTERVERTEBRAL DISC PROTRUSION 145 0.0066
443 BLOOD PRESSURE FLUCTUATION 159 0.0066
444 SKIN LACERATION 72 0.0066
445 OXYGEN SATURATION DECREASED 372 0.0066
446 TREMOR 1098 0.0066
447 UNEVALUABLE EVENT 500 0.0066
448 PROSTATIC SPECIFIC ANTIGEN INCREASED 91 0.0066
449 PLATELET COUNT INCREASED 86 0.0066
450 HEPATIC CYTOLYSIS 84 0.0066
451 LIGAMENT SPRAIN 65 0.0066
452 MUSCULOSKELETAL DISCOMFORT 113 0.0066
453 VITAMIN D DECREASED 56 0.0065
454 TRANSIENT ISCHAEMIC ATTACK 221 0.0065
455 DYSSTASIA 191 0.0065
456 SKIN ULCER 169 0.0065
457 LIVER FUNCTION TEST INCREASED 140 0.0065
458 BACK DISORDER 106 0.0065
459 ASPARTATE AMINOTRANSFERASE INCREASED 346 0.0065
460 GENERALISED OEDEMA 80 0.0065
461 INTERNATIONAL NORMALISED RATIO INCREASED 184 0.0064
462 FLUID RETENTION 328 0.0064
463 MOOD SWINGS 205 0.0064
464 DYSARTHRIA 242 0.0064
465 INSURANCE ISSUE 98 0.0064
466 HYPOTENSION 1285 0.0064
467 METASTASES TO BONE 105 0.0064
468 TEMPERATURE INTOLERANCE 66 0.0064
469 SPINAL FRACTURE 128 0.0064
470 CARDIAC FAILURE CONGESTIVE 513 0.0064
471 THROMBOSIS 513 0.0064
472 NIGHT SWEATS 205 0.0064
473 CHOLELITHIASIS 208 0.0063
474 PERIPHERAL SWELLING 977 0.0063
475 SOMNOLENCE 1276 0.0063
476 SCIATICA 101 0.0063
477 PANCYTOPENIA 354 0.0063
478 BLOOD COUNT ABNORMAL 96 0.0063
479 PAIN IN JAW 179 0.0063
480 FATIGUE 4910 0.0063
481 DEVICE RELATED INFECTION 97 0.0063
482 COAGULOPATHY 105 0.0063
483 SALIVARY HYPERSECRETION 63 0.0063
484 SINUS CONGESTION 85 0.0063
485 CARPAL TUNNEL SYNDROME 88 0.0063
486 ACUTE KIDNEY INJURY 960 0.0063
487 PERICARDIAL EFFUSION 145 0.0063
488 RESPIRATORY TRACT CONGESTION 99 0.0062
489 PETECHIAE 65 0.0062
490 SINUSITIS 637 0.0062
491 RESTLESS LEGS SYNDROME 113 0.0062
492 OBESITY 99 0.0062
493 CONCUSSION 48 0.0062
494 BURSITIS 75 0.0062
495 WHITE BLOOD CELL COUNT INCREASED 236 0.0061
496 PERSONALITY CHANGE 57 0.0061
497 NEUTROPHIL COUNT DECREASED 250 0.0061
498 EPISTAXIS 458 0.0061
499 GASTROINTESTINAL HAEMORRHAGE 511 0.0061
500 CRYING 222 0.0061
501 GALLBLADDER DISORDER 109 0.0061
502 RENAL FAILURE ACUTE 259 0.0061
503 TOOTH ABSCESS 62 0.0061
504 CONTUSION 585 0.0061
505 GLOSSODYNIA 136 0.0061
506 THINKING ABNORMAL 113 0.0061
507 MUSCLE DISORDER 49 0.0060
508 AORTIC ANEURYSM 46 0.0060
509 BONE PAIN 354 0.0060
510 NEPHROLITHIASIS 277 0.0060
511 SWELLING 565 0.0060
512 RHINORRHOEA 390 0.0060
513 GLOMERULAR FILTRATION RATE DECREASED 74 0.0060
514 ACIDOSIS 46 0.0060
515 CLOSTRIDIUM DIFFICILE INFECTION 131 0.0060
516 CHEST PAIN 1109 0.0060
517 GAIT INABILITY 200 0.0060
518 OSTEOARTHRITIS 253 0.0060
519 FOOT FRACTURE 113 0.0060
520 THROMBOCYTOPENIA 665 0.0059
521 MUSCLE RIGIDITY 71 0.0059
522 THIRST 106 0.0059
523 HEAD DISCOMFORT 105 0.0059
524 LIMB INJURY 161 0.0059
525 EAR PAIN 115 0.0059
526 EXOSTOSIS 54 0.0059
527 PHARYNGITIS STREPTOCOCCAL 64 0.0059
528 HEPATIC STEATOSIS 110 0.0059
529 HEART RATE DECREASED 207 0.0059
530 DISCOMFORT 359 0.0059
531 INTESTINAL PERFORATION 66 0.0059
532 JOINT DISLOCATION 62 0.0059
533 SUPRAVENTRICULAR TACHYCARDIA 56 0.0058
534 EMPHYSEMA 59 0.0058
535 MOOD ALTERED 159 0.0058
536 HYPOMAGNESAEMIA 81 0.0058
537 BONE DISORDER 106 0.0058
538 DISEASE PROGRESSION 687 0.0058
539 TOOTH FRACTURE 64 0.0058
540 BLOOD PRESSURE DECREASED 384 0.0058
541 DRUG INTOLERANCE 558 0.0058
542 SICKLE CELL ANAEMIA WITH CRISIS 91 0.0058
543 OEDEMA 313 0.0058
544 ANXIETY 1638 0.0057
545 RESPIRATORY RATE INCREASED 51 0.0057
546 LACERATION 54 0.0057
547 LABORATORY TEST ABNORMAL 169 0.0057
548 GAIT DISTURBANCE 1096 0.0057
549 SPINAL DISORDER 54 0.0057
550 GASTROINTESTINAL INFECTION 51 0.0057
551 TOOTHACHE 103 0.0057
552 ROTATOR CUFF SYNDROME 73 0.0057
553 PYELONEPHRITIS 49 0.0056
554 INSOMNIA 1505 0.0056
555 POST PROCEDURAL COMPLICATION 108 0.0056
556 TOOTH DISORDER 125 0.0056
557 PYREXIA 1945 0.0056
558 GENERAL PHYSICAL HEALTH DETERIORATION 650 0.0056
559 FEELING JITTERY 107 0.0056
560 HEMIPARESIS 95 0.0056
561 BRONCHITIS 415 0.0056
562 KIDNEY INFECTION 110 0.0056
563 FACIAL PAIN 50 0.0056
564 SUBDURAL HAEMATOMA 80 0.0056
565 VENTRICULAR EXTRASYSTOLES 58 0.0056
566 DIPLOPIA 145 0.0056
567 PNEUMONITIS 152 0.0056
568 HYPOKINESIA 81 0.0056
569 WOUND INFECTION 61 0.0056
570 RESPIRATORY TRACT INFECTION 145 0.0056
571 PULMONARY OEDEMA 249 0.0056
572 PERITONITIS BACTERIAL 56 0.0055
573 SPLENOMEGALY 65 0.0055
574 BLOOD PRESSURE SYSTOLIC INCREASED 108 0.0055
575 OROPHARYNGEAL DISCOMFORT 50 0.0055
576 HEMIPLEGIA 46 0.0055
577 RENAL DISORDER 257 0.0055
578 INTENTIONAL PRODUCT USE ISSUE 483 0.0055
579 DRUG EFFECT INCOMPLETE 200 0.0055
580 HYPERKALAEMIA 193 0.0055
581 SLUGGISHNESS 56 0.0055
582 CHILLS 643 0.0055
583 SWELLING FACE 356 0.0055
584 DEPRESSION 1242 0.0055
585 COUGH 1529 0.0054
586 MUSCLE ATROPHY 69 0.0054
587 ISCHAEMIC STROKE 97 0.0054
588 HAEMATURIA 186 0.0054
589 APHASIA 164 0.0054
590 HYPOTHYROIDISM 173 0.0054
591 HEART RATE INCREASED 536 0.0054
592 METASTASES TO LIVER 95 0.0054
593 NERVE INJURY 60 0.0054
594 THROAT IRRITATION 242 0.0054
595 INTENTIONAL PRODUCT MISUSE 472 0.0054
596 INCREASED APPETITE 103 0.0054
597 RENAL FAILURE 715 0.0054
598 BLOOD BILIRUBIN INCREASED 145 0.0054
599 LUNG INFECTION 83 0.0053
600 CHOLECYSTECTOMY 61 0.0053
601 MUSCLE TWITCHING 123 0.0053
602 HOT FLUSH 402 0.0053
603 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 256 0.0053
604 OROPHARYNGEAL PAIN 493 0.0053
605 BLOOD THYROID STIMULATING HORMONE INCREASED 49 0.0053
606 PERIPHERAL COLDNESS 73 0.0053
607 FUNGAL INFECTION 177 0.0053
608 HYPOAESTHESIA ORAL 80 0.0053
609 TRANSAMINASES INCREASED 118 0.0053
610 HYPERTENSION 1123 0.0053
611 MALIGNANT NEOPLASM PROGRESSION 542 0.0053
612 HEPATOMEGALY 52 0.0053
613 EMOTIONAL DISORDER 163 0.0053
614 LOCAL SWELLING 92 0.0053
615 HEART RATE IRREGULAR 119 0.0053
616 DIZZINESS 2625 0.0053
617 GASTRIC ULCER 100 0.0053
618 EAR DISCOMFORT 54 0.0053
619 TOOTH INFECTION 69 0.0052
620 AGITATION 384 0.0052
621 HOSPITALISATION 803 0.0052
622 EYE INFECTION 59 0.0052
623 HEREDITARY ANGIOEDEMA 56 0.0052
624 SYNCOPE 522 0.0052
625 OBSTRUCTIVE AIRWAYS DISORDER 58 0.0052
626 HYPERBILIRUBINAEMIA 54 0.0052
627 CARDIOMYOPATHY 77 0.0052
628 GINGIVAL BLEEDING 71 0.0052
629 SPINAL OPERATION 64 0.0052
630 MENTAL DISORDER 226 0.0052
631 BODY TEMPERATURE DECREASED 51 0.0052
632 HYPOCALCAEMIA 98 0.0052
633 UPPER LIMB FRACTURE 103 0.0052
634 LOCALISED INFECTION 125 0.0052
635 NERVOUSNESS 270 0.0052
636 MUSCULOSKELETAL PAIN 270 0.0051
637 MASS 72 0.0051
638 WRONG TECHNIQUE IN DRUG USAGE PROCESS 187 0.0051
639 PULMONARY FIBROSIS 98 0.0051
640 DYSPNOEA 2891 0.0051
641 COGNITIVE DISORDER 238 0.0051
642 COORDINATION ABNORMAL 71 0.0051
643 NO THERAPEUTIC RESPONSE 62 0.0051
644 OVERDOSE 1095 0.0051
645 LIMB DISCOMFORT 157 0.0051
646 NASAL CONGESTION 298 0.0051
647 THYROID DISORDER 78 0.0051
648 IMPAIRED HEALING 166 0.0051
649 FEELING ABNORMAL 1210 0.0050
650 OSTEOPOROSIS 207 0.0050
651 COMPLICATION ASSOCIATED WITH DEVICE 73 0.0050
652 PAIN 3086 0.0050
653 RENAL PAIN 53 0.0050
654 BODY TEMPERATURE INCREASED 102 0.0050
655 OCULAR DISCOMFORT 56 0.0050
656 ANHEDONIA 131 0.0050
657 IRRITABILITY 299 0.0050
658 HAEMATEMESIS 126 0.0050
659 MUCOSAL INFLAMMATION 130 0.0050
660 SEDATION 130 0.0050
661 TUBULOINTERSTITIAL NEPHRITIS 93 0.0050
662 DIABETES MELLITUS 377 0.0049
663 INTENTIONAL DOSE OMISSION 141 0.0049
664 ADRENAL INSUFFICIENCY 60 0.0049
665 HYPOAESTHESIA 740 0.0049
666 LYMPHADENOPATHY 175 0.0049
667 METASTASES TO LUNG 57 0.0049
668 ILLNESS 507 0.0049
669 SKIN DISCOLOURATION 226 0.0049
670 DELIRIUM 170 0.0049
671 TACHYCARDIA 435 0.0049
672 SEPTIC SHOCK 213 0.0049
673 HYPERHIDROSIS 630 0.0049
674 HYPERGLYCAEMIA 178 0.0049
675 PAIN IN EXTREMITY 1436 0.0049
676 BEDRIDDEN 64 0.0049
677 LOWER LIMB FRACTURE 93 0.0048
678 HAIR COLOUR CHANGES 60 0.0048
679 ALANINE AMINOTRANSFERASE INCREASED 294 0.0048
680 NEUTROPHIL COUNT INCREASED 49 0.0048
681 FOOT DEFORMITY 53 0.0048
682 INFLUENZA 533 0.0048
683 WHEEZING 283 0.0048
684 AGEUSIA 119 0.0048
685 BURNING SENSATION 334 0.0048
686 MEMORY IMPAIRMENT 654 0.0048
687 DISORIENTATION 188 0.0047
688 MUSCULOSKELETAL STIFFNESS 415 0.0047
689 MOVEMENT DISORDER 152 0.0047
690 COVID-19 828 0.0047
691 EYE DISCHARGE 49 0.0047
692 NIGHTMARE 163 0.0047
693 ARTHRITIS 370 0.0047
694 MOUTH ULCERATION 99 0.0047
695 LUNG DISORDER 230 0.0047
696 BIPOLAR DISORDER 51 0.0047
697 CONTRAINDICATED PRODUCT ADMINISTERED 142 0.0047
698 AMNESIA 305 0.0047
699 FEAR 126 0.0047
700 SENSORY DISTURBANCE 75 0.0047
701 MYOCARDIAL ISCHAEMIA 53 0.0047
702 GENERALISED TONIC-CLONIC SEIZURE 77 0.0046
703 INFECTION 673 0.0046
704 DRY EYE 232 0.0046
705 SKIN DISORDER 155 0.0046
706 IMMUNODEFICIENCY 69 0.0046
707 DRUG LEVEL DECREASED 47 0.0046
708 CATARACT 274 0.0046
709 CONDITION AGGRAVATED 1398 0.0046
710 BREAST PAIN 49 0.0046
711 HAEMATOMA 119 0.0046
712 HEADACHE 2875 0.0046
713 ABSCESS 73 0.0046
714 OSTEONECROSIS OF JAW 113 0.0046
715 MALAISE 2001 0.0046
716 PANIC ATTACK 166 0.0046
717 INJURY 320 0.0045
718 COLD SWEAT 80 0.0045
719 IMPAIRED QUALITY OF LIFE 65 0.0045
720 CYST 56 0.0045
721 LOSS OF CONSCIOUSNESS 578 0.0045
722 INFUSION RELATED REACTION 299 0.0045
723 MIGRAINE 430 0.0045
724 CONVULSION 257 0.0045
725 TACHYPNOEA 61 0.0045
726 RASH PRURITIC 243 0.0045
727 NEOPLASM PROGRESSION 155 0.0045
728 PRODUCT ADMINISTRATION ERROR 90 0.0044
729 HUNGER 62 0.0044
730 PRODUCT DOSE OMISSION IN ERROR 126 0.0044
731 PHARYNGITIS 55 0.0044
732 EYE PAIN 250 0.0044
733 MOBILITY DECREASED 318 0.0044
734 WEIGHT INCREASED 991 0.0044
735 CARDIO-RESPIRATORY ARREST 185 0.0044
736 PHOTOSENSITIVITY REACTION 73 0.0044
737 PULMONARY ARTERIAL HYPERTENSION 64 0.0044
738 CYTOPENIA 54 0.0044
739 PALLOR 120 0.0044
740 ANKLE FRACTURE 68 0.0044
741 NEUTROPENIA 597 0.0044
742 CARDIAC ARREST 362 0.0044
743 RESPIRATORY DISORDER 131 0.0044
744 ADVERSE REACTION 58 0.0044
745 HEPATIC ENZYME INCREASED 296 0.0043
746 WOUND 121 0.0043
747 RASH PAPULAR 97 0.0043
748 SCAR 74 0.0043
749 SKIN CANCER 93 0.0043
750 SCAB 49 0.0043
751 ACTIVITIES OF DAILY LIVING IMPAIRED 85 0.0043
752 PANCREATITIS 226 0.0043
753 ANOREXIA 55 0.0043
754 TOOTH EXTRACTION 53 0.0043
755 WRIST FRACTURE 51 0.0043
756 SURGERY 249 0.0042
757 BLOOD TRIGLYCERIDES INCREASED 75 0.0042
758 TINNITUS 195 0.0042
759 CHEST DISCOMFORT 434 0.0042
760 COVID-19 PNEUMONIA 50 0.0042
761 VERTIGO 258 0.0042
762 DIALYSIS 60 0.0042
763 PHARYNGEAL OEDEMA 65 0.0042
764 PSYCHOMOTOR HYPERACTIVITY 70 0.0042
765 HERPES ZOSTER 242 0.0042
766 SKIN LESION 115 0.0042
767 TREATMENT NONCOMPLIANCE 229 0.0042
768 STATUS EPILEPTICUS 47 0.0042
769 LIVER FUNCTION TEST ABNORMAL 121 0.0042
770 ACCIDENTAL OVERDOSE 152 0.0042
771 ADVERSE DRUG REACTION 373 0.0041
772 CENTRAL NERVOUS SYSTEM LESION 57 0.0041
773 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 96 0.0041
774 BRAIN OEDEMA 52 0.0041
775 HIP ARTHROPLASTY 63 0.0041
776 RENAL INJURY 122 0.0041
777 ACUTE MYELOID LEUKAEMIA 64 0.0041
778 RASH 1787 0.0041
779 ORAL HERPES 80 0.0041
780 RASH MACULAR 143 0.0041
781 PRODUCT DOSE OMISSION ISSUE 1201 0.0041
782 ACUTE MYOCARDIAL INFARCTION 120 0.0041
783 NODULE 53 0.0041
784 ELECTROCARDIOGRAM QT PROLONGED 146 0.0041
785 PANCREATITIS ACUTE 91 0.0040
786 MENTAL IMPAIRMENT 98 0.0040
787 PHOTOPHOBIA 76 0.0040
788 POST PROCEDURAL HAEMORRHAGE 47 0.0040
789 THROAT TIGHTNESS 109 0.0040
790 PALPITATIONS 471 0.0040
791 RESPIRATORY DEPRESSION 49 0.0040
792 BRONCHOSPASM 57 0.0040
793 BASAL CELL CARCINOMA 62 0.0040
794 NASOPHARYNGITIS 732 0.0040
795 GAMMA-GLUTAMYLTRANSFERASE INCREASED 88 0.0040
796 RESTLESSNESS 145 0.0040
797 BRADYCARDIA 210 0.0040
798 VISION BLURRED 543 0.0040
799 METASTASES TO CENTRAL NERVOUS SYSTEM 51 0.0040
800 KNEE ARTHROPLASTY 83 0.0039
801 LACRIMATION INCREASED 119 0.0039
802 PRODUCT QUALITY ISSUE 533 0.0039
803 RASH MACULO-PAPULAR 87 0.0039
804 PSYCHOTIC DISORDER 115 0.0039
805 EOSINOPHILIA 68 0.0039
806 NERVOUS SYSTEM DISORDER 121 0.0039
807 PARAESTHESIA 607 0.0039
808 HYPOACUSIS 166 0.0039
809 PELVIC PAIN 70 0.0038
810 COLITIS ULCERATIVE 172 0.0038
811 ARTHRALGIA 1591 0.0038
812 DEPRESSED MOOD 202 0.0038
813 MELAENA 84 0.0038
814 HAEMORRHAGE INTRACRANIAL 57 0.0038
815 MALIGNANT MELANOMA 51 0.0038
816 EYE DISORDER 125 0.0038
817 THERAPY CESSATION 195 0.0038
818 METABOLIC ACIDOSIS 121 0.0038
819 BLISTER 212 0.0038
820 PARALYSIS 54 0.0038
821 NEUROTOXICITY 66 0.0038
822 JOINT SWELLING 454 0.0038
823 VENTRICULAR TACHYCARDIA 62 0.0038
824 LIP SWELLING 125 0.0037
825 MYALGIA 637 0.0037
826 PRURITUS GENERALISED 81 0.0037
827 JOINT STIFFNESS 98 0.0037
828 EJECTION FRACTION DECREASED 58 0.0037
829 ACUTE RESPIRATORY DISTRESS SYNDROME 66 0.0037
830 MANIA 61 0.0037
831 THERAPY INTERRUPTED 264 0.0037
832 DISTURBANCE IN ATTENTION 199 0.0037
833 PRURITUS 1416 0.0037
834 ABASIA 91 0.0037
835 ROAD TRAFFIC ACCIDENT 154 0.0037
836 DEVICE FAILURE 56 0.0037
837 ASTHMA 415 0.0037
838 FEELING HOT 225 0.0037
839 CONJUNCTIVITIS 68 0.0037
840 ANGINA PECTORIS 105 0.0037
841 MYELODYSPLASTIC SYNDROME 53 0.0037
842 FEMUR FRACTURE 113 0.0036
843 COLON CANCER 54 0.0036
844 PERITONITIS 75 0.0036
845 SNEEZING 81 0.0036
846 ANGIOEDEMA 159 0.0036
847 HAIR TEXTURE ABNORMAL 48 0.0036
848 BLOOD GLUCOSE ABNORMAL 66 0.0036
849 ARRHYTHMIA 168 0.0035
850 ARTHROPATHY 197 0.0035
851 BLOOD GLUCOSE DECREASED 170 0.0035
852 PRODUCT DOSE OMISSION 230 0.0035
853 DEAFNESS 92 0.0035
854 RASH ERYTHEMATOUS 168 0.0035
855 HEPATIC CIRRHOSIS 66 0.0035
856 SKIN HAEMORRHAGE 52 0.0035
857 HYPERSENSITIVITY 650 0.0035
858 IMMUNE SYSTEM DISORDER 46 0.0035
859 HYPOGLYCAEMIA 169 0.0035
860 EYE SWELLING 129 0.0035
861 HALLUCINATION, AUDITORY 55 0.0035
862 ABNORMAL DREAMS 95 0.0034
863 ERYTHEMA 705 0.0034
864 TYPE 2 DIABETES MELLITUS 115 0.0034
865 DRY SKIN 455 0.0034
866 URTICARIA 571 0.0034
867 DYSTONIA 66 0.0034
868 DEATH 2916 0.0034
869 DRUG LEVEL INCREASED 56 0.0034
870 LEUKOPENIA 169 0.0034
871 APHONIA 47 0.0034
872 ADVERSE EVENT 309 0.0033
873 CEREBROVASCULAR ACCIDENT 564 0.0033
874 LYMPHOPENIA 47 0.0033
875 HAEMORRHAGE 346 0.0033
876 IMPAIRED WORK ABILITY 70 0.0033
877 GLAUCOMA 63 0.0033
878 THERAPY NON-RESPONDER 147 0.0033
879 PROTEINURIA 62 0.0033
880 MUSCULOSKELETAL DISORDER 62 0.0033
881 MULTIPLE SCLEROSIS 155 0.0032
882 TOOTH LOSS 67 0.0032
883 CARDIAC DISORDER 302 0.0032
884 MULTIPLE SCLEROSIS RELAPSE 220 0.0032
885 FLUSHING 324 0.0032
886 HYPERTHYROIDISM 46 0.0032
887 ANAPHYLACTIC REACTION 175 0.0032
888 RASH GENERALISED 82 0.0032
889 DERMATITIS 66 0.0031
890 RENAL IMPAIRMENT 264 0.0031
891 VISUAL IMPAIRMENT 389 0.0031
892 DEPRESSED LEVEL OF CONSCIOUSNESS 124 0.0031
893 JAUNDICE 84 0.0031
894 BONE MARROW FAILURE 63 0.0031
895 PHARMACEUTICAL PRODUCT COMPLAINT 80 0.0031
896 LOWER RESPIRATORY TRACT INFECTION 140 0.0031
897 ALOPECIA 597 0.0030
898 INFLUENZA LIKE ILLNESS 250 0.0030
899 BLOOD CREATINE PHOSPHOKINASE INCREASED 87 0.0030
900 LIVER DISORDER 134 0.0030
901 HEPATIC FAILURE 91 0.0030
902 THERAPEUTIC RESPONSE DECREASED 183 0.0030
903 EYE PRURITUS 100 0.0030
904 CEREBRAL HAEMORRHAGE 106 0.0030
905 RESPIRATORY ARREST 81 0.0029
906 BLOOD GLUCOSE INCREASED 553 0.0029
907 INTENTIONAL SELF-INJURY 59 0.0029
908 ALTERED STATE OF CONSCIOUSNESS 63 0.0029
909 EYE IRRITATION 165 0.0029
910 SKIN EXFOLIATION 241 0.0029
911 DEVICE DISLOCATION 124 0.0028
912 OCULAR HYPERAEMIA 135 0.0028
913 FRACTURE 53 0.0028
914 ILL-DEFINED DISORDER 166 0.0027
915 THERAPEUTIC RESPONSE SHORTENED 89 0.0027
916 DRUG DOSE OMISSION 442 0.0027
917 SUICIDAL IDEATION 242 0.0026
918 AGRANULOCYTOSIS 49 0.0026
919 SKIN FISSURES 51 0.0026
920 CARDIAC FAILURE 209 0.0026
921 DEVICE ISSUE 233 0.0026
922 DISABILITY 51 0.0026
923 CARDIOVASCULAR DISORDER 65 0.0026
924 CHOLESTASIS 49 0.0025
925 HEPATITIS 65 0.0025
926 MEDICATION ERROR 141 0.0025
927 ECZEMA 130 0.0025
928 LACTIC ACIDOSIS 80 0.0025
929 WITHDRAWAL SYNDROME 103 0.0025
930 DISEASE RECURRENCE 116 0.0024
931 NEOPLASM MALIGNANT 162 0.0024
932 TARDIVE DYSKINESIA 68 0.0024
933 SHOCK 55 0.0024
934 EXTRAPYRAMIDAL DISORDER 59 0.0024
935 PRODUCT SUBSTITUTION ISSUE 136 0.0024
936 DRUG INTERACTION 373 0.0023
937 INFLAMMATION 119 0.0023
938 GLYCOSYLATED HAEMOGLOBIN INCREASED 58 0.0023
939 PRODUCT DISPENSING ERROR 50 0.0023
940 NO ADVERSE EVENT 415 0.0023
941 EMOTIONAL DISTRESS 272 0.0022
942 PAIN OF SKIN 60 0.0022
943 C-REACTIVE PROTEIN INCREASED 80 0.0022
944 VAGINAL HAEMORRHAGE 95 0.0022
945 CEREBRAL INFARCTION 53 0.0022
946 EPILEPSY 66 0.0022
947 BLINDNESS 87 0.0021
948 RHABDOMYOLYSIS 89 0.0021
949 SYSTEMIC LUPUS ERYTHEMATOSUS 75 0.0021
950 COMA 100 0.0021
951 ACNE 158 0.0021
952 MYOCARDIAL INFARCTION 359 0.0021
953 DRUG WITHDRAWAL SYNDROME 180 0.0020
954 LUNG NEOPLASM MALIGNANT 82 0.0020
955 VISUAL ACUITY REDUCED 66 0.0020
956 BONE DENSITY DECREASED 61 0.0019
957 DRUG DEPENDENCE 313 0.0019
958 PANCREATIC CARCINOMA 52 0.0018
959 NEEDLE ISSUE 52 0.0018
960 OSTEONECROSIS 58 0.0018
961 INJECTION SITE MASS 65 0.0018
962 APPLICATION SITE ERYTHEMA 46 0.0018
963 INJECTION SITE BRUISING 130 0.0016
964 INTERSTITIAL LUNG DISEASE 78 0.0016
965 INCORRECT ROUTE OF DRUG ADMINISTRATION 57 0.0016
966 MATERNAL EXPOSURE DURING PREGNANCY 142 0.0016
967 DEVICE BREAKAGE 64 0.0016
968 DRUG-INDUCED LIVER INJURY 49 0.0016
969 DEVICE LEAKAGE 66 0.0015
970 SKIN IRRITATION 69 0.0015
971 INJECTION SITE PRURITUS 100 0.0015
972 INJECTION SITE ERYTHEMA 181 0.0015
973 INJECTION SITE SWELLING 103 0.0013
974 DEVICE MALFUNCTION 92 0.0013
975 DRUG ABUSE 106 0.0013
976 RHEUMATOID ARTHRITIS 142 0.0012
977 EXPOSURE DURING PREGNANCY 77 0.0012
978 TREATMENT FAILURE 100 0.0012
979 SUICIDE ATTEMPT 73 0.0012
980 INJECTION SITE PAIN 361 0.0012
981 INJECTION SITE REACTION 79 0.0011
982 INJECTION SITE HAEMORRHAGE 91 0.0011
983 TOXICITY TO VARIOUS AGENTS 189 0.0011
984 PSORIASIS 137 0.0010
985 SKIN BURNING SENSATION 74 0.0010
986 PRODUCT STORAGE ERROR 81 0.0009
987 ACCIDENTAL EXPOSURE TO PRODUCT 94 0.0009
988 BREAST CANCER 84 0.0009
989 INTENTIONAL OVERDOSE 56 0.0009
990 PROSTATE CANCER 64 0.0008
991 FOETAL EXPOSURE DURING PREGNANCY 56 0.0007